Specific Stem Cell Therapy(GIOSTAR)

N/A

Report date: 2024/11/15 10:49:34

Base Information

Drug NameSpecific Stem Cell Therapy(GIOSTAR)

Drug Alias NameDT2-SCT

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derived

Mechanisms of ActionStem cell replacements

TargetsUpdating

Therapy Area/IndicationsDiabetes Mellitus, Type 2

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesGlobal Institute of Stem Cell Therapy and Research Inc

China Registration ClassN/A

Develop Information

Active CompaniesGlobal Institute of Stem Cell Therapy and Research Inc

Inactive CompaniesN/A

Active IndicationsDiabetes Mellitus, Type 2

Inactive IndicationsN/A

Other Information

ATC CodeN/A